Correction to Lancet Glob Health 2019; 7: e861–71 (The Lancet Global Health (2019) 7(7) (e861–e871), (S2214109X19300713), (10.1016/S2214-109X(19)30071-3));Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries

The Lancet Global Health

Volumn 7, Issue 7, 2019, Pages e861-e871

  Hsia, Yingfen ^a   Lee, Brian R ^b   Versporten, Ann ^c   Yang, Yonghong ^d,e   Bielicki, Julia ^a,f   Jackson, Charlotte ^a   Newland, Jason ^g   Goossens, Herman ^c   Magrini, Nicola ^h   Sharland, Mike ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CHILDREN S MERCY KANSAS CITY   (United States)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e SHENZHEN CHILDREN'S HOSPITAL   (China)

^f UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CEFAZOLIN; CEFEPIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DAPTOMYCIN; ERTAPENEM; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; LATAMOXEF; MEROPENEM; METRONIDAZOLE; OXACILLIN; PENICILLIN G; PIPERACILLIN; TEICOPLANIN; TOBRAMYCIN; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL STEWARDSHIP; ARTICLE; BURN; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; DRUG USE; DRUG UTILIZATION; FEBRILE NEUTROPENIA; FEVER; GASTROINTESTINAL INFECTION; HOSPITAL MEDICINE; HOSPITAL PATIENT; HOSPITALIZED INFANT; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SEPSIS; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL INFECTION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; ADOLESCENT; HEALTH CARE SURVEY; HOSPITAL PHARMACY; INFANT; PEDIATRICS; PRESCHOOL CHILD; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL STEWARDSHIP; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; HEALTH CARE SURVEYS; HUMANS; INFANT; INFANT, NEWBORN; PEDIATRICS; PHARMACY SERVICE, HOSPITAL; WORLD HEALTH ORGANIZATION;

EID: 85066982316     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(21)00179-0     Document Type: Erratum

References (34)

1. WHO. Global action plan on antimicrobial resistance. http://www.wpro.who.int/entity/drug_resistance/resources/global_action_plan_eng.pdf. (Accessed 13 April 2018)
2. WHO. Antimicrobial resistance: global report on surveillance. http://www.who.int/drugresistance/documents/surveillancereport/en/, 2014. (Accessed 18 March 2018)
3. Porta, A, Hsia, Y, Doerholt, K, et al. Comparing neonatal and paediatric antibiotic prescribing between hospitals: a new algorithm to help international benchmarking. J Antimicrob Chemother 67 (2012), 1278–1286.
4. Di Pentima, MC, Chan, S, Hossain, J, Benefits of a pediatric antimicrobial stewardship program at a children's hospital. Pediatrics 128 (2011), 1062–1070.
5. WHO. Executive summary: the selection and use of essential medicines. Report of the 21st WHO Expert Committee on the Selection and Use of Essential Medicines. http://www.who.int/medicines/publications/essentialmedicines/EML_2017_ExecutiveSummary.pdf. (Accessed 18 March 2018)
6. (AGISAR) WAGoISoAR. Critically important antimicrobials for human medicine. http://www.who.int/foodsafety/publications/antimicrobials-fifth/en/ 5th revision 2016. (Accessed 18 March 2018)
7. Sharland, M, Pulcini, C, Harbarth, S, et al. Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe. Lancet Infect Dis 18 (2018), 18–20.
8. Versporten, A, Bielicki, J, Drapier, N, et al. The worldwide antibiotic resistance and prescribing in european children (ARPEC) point prevalence survey: Developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother 71 (2016), 1106–1117.
9. Versporten, A, Sharland, M, Bielicki, J, et al. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J 32 (2013), e242–e253.
10. Versporten, A, Zarb, P, Caniaux, I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health 6 (2018), e619–e629.
11. Newland, JG, Gerber, JS, Kronman, MP, et al. Sharing antimicrobial reports for pediatric stewardship (sharps): a quality improvement collaborative. J Pediatr Infect Dis Soc 7 (2017), 124–128.
12. WHO. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment. https://wwwwhoccno/atc_ddd_index/, 2018.
13. Bergman, U, Popa, C, Tomson, Y, et al. Drug utilization 90%—a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 54 (1998), 113–118.
14. de Bie, S, Kaguelidou, F, Verhamme, KM, et al. Using prescription patterns in primary care to derive new quality indicators for childhood community antibiotic prescribing. Pediatr Infect Dis J 35 (2016), 1317–1323.
15. Laxminarayan, R, Matsoso, P, Pant, S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet 387 (2016), 168–175.
16. Cox, JA, Vlieghe, E, Mendelson, M, et al. Antibiotic stewardship in low- and middle-income countries: the same but different?. Clin Microbiol Infect 23 (2017), 812–818.
17. Hsia, Y, Sharland, M, Jackson, C, Wong, ICK, Magrini, N, Bielicki, JA, Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle and high-income countries. Lancet Infect Dis 19 (2019), 67–75.
18. Amadeo B, Zarb P, Muller A, et al. European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother; 65: 2247–52.
19. De Luca, M, Dona, D, Montagnani, C, et al. Antibiotic prescriptions and prophylaxis in Italian children. Is it time to change? Data from the ARPEC project. PLoS One, 11, 2016, e0154662.
20. Gandra, S, Alvarez-Uria, G, Murki, S, et al. Point prevalence surveys of antimicrobial use among eight neonatal intensive. Int J Infect Dis 71 (2018), 20–24.
21. Gandra, S, Singh, SK, Jinka, DR, et al. Point prevalence surveys of antimicrobial use among hospitalized children in six hospitals in India in 2016. Antibiotics, 6, 2017, 19.
22. Gharbi, M, Doerholt, K, Vergnano, S, et al. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK. BMJ Open, 6, 2016, e012675.
23. Osowicki, J, Gwee, A, Noronha, J, et al. Australia-wide point prevalence survey of antimicrobial prescribing in neonatal units: how much and how good?. Pediatr Infect Dis J 34 (2015), e185–e190.
24. Fahimzad, A, Eydian, Z, Karimi, A, et al. Surveillance of antibiotic consumption point prevalence survey 2014: antimicrobial prescribing in pediatrics wards of 16 Iranian hospitals. Arch Iran Med 19 (2014), 204–209.
25. Fahimzad, A EZ, Karimi, A, Shiva, F, Armin, S, et al. Antibiotic prescribing pattern in neonates of seventeen Iranian hospitals. Arch Pediatr Infect Dis, 5, 2017, e61630.
26. Hufnagel, M, Versporten, A, Bielicki, J, et al. High rates of prescribing antimicrobials for prophylaxis in children and neonates: results from the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey. J Pediatr Infect Dis Soc, 2018 published online March 22. DOI:10.1093/jpids/piy019.
27. Osowicki, J, Gwee, A, Noronha, J, Australia-wide point prevalence survey of the use and appropriateness of antimicrobial prescribing for children in hospital. Med J Aust 201 (2014), 657–662.
28. Al Salman, J, Al Agha, R, Antibiotics surveillance in pediatrics in-patients, a point prevalence comparative study between Kingdom of Bahrain and the European Union. Bahrain Med Bull 36 (2014), 20–24.
29. Ceyhan, M, Yildirim, I, Ecevit, C, et al. Inappropriate antimicrobial use in Turkish pediatric hospitals: a multicenter point prevalence survey. Int J Infect Dis 14 (2010), e55–e61.
30. Ciofi Degli Atti, ML, Raponi, M, Tozzi, AE, Ciliento, G, Ceradini, J, Langiano, T, Point prevalence study of antibiotic use in a paediatric hospital in Italy. Euro Surveill, 13, 2008, 19003.
31. Zingg, W, Hopkins, S, Gayet-Ageron, A, et al. Health-care-associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey. Lancet Infect Dis 17 (2017), 381–389.
32. Pathak, A, Mahadik, K, Dhaneria, SP, Sharma, A, Eriksson, B, Lundborg, CS, Antibiotic prescribing in outpatients: hospital and seasonal variations in Ujjain, India. Scand J Infect Dis 43 (2011), 479–488.
33. Kotwani, A, Holloway, K, Trends in antibiotic use among outpatients in New Delhi, India. BMC Infect Dis, 11, 2011, 99.
34. Bielicki, JA, Sharland, M, Versporten, A, Goossens, H, Cromwell, DA, Using risk adjustment to improve the interpretation of global inpatient pediatric antibiotic prescribing. PLoS One, 13, 2018, e0199878.